API Market Size, Share, Trends, Growth, Industry Analysis and Forecast 2025

Global API market is estimated to witness a growth rate of around 6.5% over the period of 2019-2025. Growing prevalence of chronic and acute diseases, growing focus on precision medicine, and surging biopharmaceutical industries across the globe are driving the global API market. According to the WHO, around 17.9 million fatalities occurred globally due to cardiovascular diseases (CVDs) in 2016, representing around 31% of global fatalities. Amongst these fatalities, around 7.4 million were due to coronary heart diseases (CHD) and nearly 6.7 million were due to stroke. By 2030, it has been projected that CVDs would be responsible for nearly 23.6 million mortalities across the globe. These facts and figures reflect the demand for various pharmaceuticals drugs, which in turn, augments the demand for APIs.

Get Sample Copy of Global API Market at: https://www.omrglobal.com/request-sample/api-market

Some of the prominent players that contribute significantly in the market include Teva Pharmaceutical Industries Ltd., Cipla Ltd., Almac Group, Sun Pharmaceutical Industries Ltd., and Thermo Fisher Scientific Inc.

The global API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. The growth of the branded segment is due to greater demand for patented drugs and their effectiveness as compared to generic drugs. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the global API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. NSAIDs therapeutics segment held the leading position in 2018.

For More Information, get A full report of Global API Market is available at: https://www.omrglobal.com/industry-reports/api-market

Geographically, the market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America imports the majority of API from Asian and Sub-Saharan African countries and is estimated to dominate the global API market over the forecast period. Major factors backing the growth of the North American API market include the presence of major pharmaceutical firms such as Abbott Laboratories, AbbVie Inc., Dr. Reddy's Laboratories Ltd., and so on. The global API market is fragmented in nature with the presence of various players operating in the market. Teva Pharmaceutical Industries Ltd. is one of the major players in the global API market. The strong foothold of the company is attributed to its broad portfolio of more than 370 high-quality API products.

Market Segmentation

Global API Market by Type

o General API
o Branded API

Global API Market by Type of Synthesis

o Biotech API
o Synthetic API
o Others (High Potency API)

Global API Market by Therapeutics

o Cardiovascular Drugs
o Oncology Drugs
o Neurology Drugs
o Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
o Others (Orthopedic Drugs)

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/api-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.